Alteplase versus urokinase for occluded hemodialysis cathetersZACHARIAS, James M; WEATHERSTON, Christine P; SPEWAK, Candace R et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 27-33, issn 1060-0280, 7 p.Article

Amyloid β peptides stimulate tissue-type plasminogen activator but not recombinant prourokinaseWNENDT, S; WETZELS, I; GÜNZLER, W. A et al.Thrombosis research. 1997, Vol 85, Num 3, pp 217-224, issn 0049-3848Article

A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusionsTHOMMI, G; SHEHAN, J. C; ROBISON, K. L et al.Respiratory medicine. 2012, Vol 106, Num 5, pp 716-723, issn 0954-6111, 8 p.Article

6 Ans après GUSTO-1… Permeabilité artérielle, fonction ventriculaire et mortalité = 6 years after GUSTO-1... Arterial permeability, ventricular fonction and mortalityBASSAND, J.-P.Etudes & évaluation cardio-vasculaires. 1998, Vol 5, Num 8, pp 305-313, issn 1251-3571Article

A fresh look at the molecular pharmacology of plasminogen activators : From theory to test tube to clinical outcomesSMALLING, R. W.American journal of health-system pharmacy. 1997, Vol 54, Num 22, pp S17-S22, issn 1079-2082, SUP1Conference Paper

The production of improved tissue-type plasminogen activator in Escherichia coliMATTES, Ralf.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 4, pp 325-335, issn 0094-6176Article

Bioactivity of cryopreserved alteplase solutionsCALIS, K. A; CULLINANE, A. M; HORNE, M. K et al.American journal of health-system pharmacy. 1999, Vol 56, Num 20, pp 2056-2057, issn 1079-2082Article

Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA)TRUSEN, B; RIES, M; ZENKER, M et al.Seminars in thrombosis and hemostasis. 1998, Vol 24, Num 6, pp 599-604, issn 0094-6176Article

Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide)GRAM, J; KOLD, A; JESPERSEN, J et al.Journal of internal medicine. 1989, Vol 225, Num 4, pp 241-247, issn 0954-6820, 7 p.Article

Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolismMÜHL, Diána; GHOSH, Subhamay; UZUELLI, Juliana A et al.Thrombosis research. 2010, Vol 125, Num 6, pp 549-553, issn 0049-3848, 5 p.Article

Tissue plasminogen activator blood level in preterm infantsCOHEN, A. M; DULITZKY, F; SIROTA, L et al.Israel journal of medical sciences. 1993, Vol 29, Num 4, pp 204-207, issn 0021-2180Article

Clinical experience with tissue plasminogen activator stored at -20°CGREWING, R; MESTER, U; LÖW, M et al.Ophthalmic surgery. 1992, Vol 23, Num 11, pp 780-781, issn 0022-023XArticle

Lysis of middle-cerebral-artery occlusion with alteplaseSAKURAI, J; EGASHIRA, T; YAMADA, Y et al.Lancet (British edition). 1991, Vol 338, Num 8776, pp 1206-1207, issn 0140-6736Article

Plasminogen steal and clot lysisTORR, S. R; NACHOWIAK, D. A; FUJII, S et al.Journal of the American College of Cardiology. 1992, Vol 19, Num 5, pp 1085-1090, issn 0735-1097Article

Fibrinolyse dans le traitement de l'amaurosis fugax : À propos d'un cas = Fibrinolysis in the treatment of the amaurosis fugax: a case reportDERIEUX, L; GUYOMARD, J.-L; CATIER, A et al.Journal français d'ophtalmologie. 2003, Vol 26, Num 5, pp 507-509, issn 0181-5512, 3 p.Article

Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditionsHATTENBACH, Lars-Olof; KLAIS, Christina; KOCH, Frank H. J et al.Ophthalmology (Rochester, MN). 2001, Vol 108, Num 8, pp 1485-1492, issn 0161-6420Article

Use of Tissue plasminogen activator to revive blebs following intraocular surgerySMITH, M. Fran; DOYLE, J. William.Archives of ophthalmology (1960). 2001, Vol 119, Num 6, pp 809-812, issn 0003-9950Article

A prodrug approach for delivery of t-PA : Construction of the cationic t-PA prodrug by a recombinant method and preliminary in vitro evaluation of the constructHUI SONG; LIANG, Jun F; YANG, Victor C et al.ASAIO journal (1992). 2000, Vol 46, Num 6, pp 663-668, issn 1058-2916Article

Expression and localisation of urokinase-type plasminogen activator gene in gliomasZHANG, X; BU, X.-Y; ZHEN, H.-N et al.Journal of clinical neuroscience. 2000, Vol 7, Num 2, pp 116-119, issn 0967-5868Article

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolismTEBBE, U; GRAF, A; KAMKE, W et al.The American heart journal. 1999, Vol 138, Num 1, pp 39-44, issn 0002-8703, 1Article

Intravitreale rt-PA-und Gaseingabe bei submakulärer Blutung = Intravitreal tissue plasminogen activator and gas in submacular hemorrhageBUHL, M; SCHEIDER, A; SCHÖNFELD, C.-L et al.Der Ophthalmologe (Berlin. Print). 1999, Vol 96, Num 12, pp 792-796, issn 0941-293XConference Paper

Systemische Lysetherapie bei retinalen Gefässverschlüssen = Fibrinolytic therapy in retinal vessel occlusionHATTENBACH, L.-O.Der Ophthalmologe (Berlin. Print). 1998, Vol 95, Num 8, pp 568-575, issn 0941-293XArticle

Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhageSAIKA, S; YAMANAKA, AKIFUMI; OHKAWA, K et al.Graefe's archive for clinical and experimental ophthalmology. 1998, Vol 236, Num 3, pp 196-201, issn 0721-832XArticle

Can we improve on front-loaded alteplase (r-TAP)AYLWARD, P.Australian and New Zealand journal of medicine. 1998, Vol 28, Num 4, pp 511-513, issn 0004-8291Conference Paper

Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancyFLEYFEL, M; BOURZOUFI, K; HUIN, G et al.Canadian journal of anaesthesia. 1997, Vol 44, Num 7, pp 735-738, issn 0832-610XArticle